CHERICO BOWMAN: Open Payments
NPI 1740956416 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,104 in 26 payments from 11 companies in 2025. Trend: 2023 $382 · 2024 $426 · 2025 $1,104
Food & beverage: $1,104
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $229 |
| Lilly USA, LLC | 6 | $199 |
| C2N Diagnostics, LLC | 3 | $170 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Bausch & Lomb Americas Inc. | 1 | $122 |
| GlaxoSmithKline, LLC. | 3 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| Dynavax Technologies Corporation | 3 | $39 |
| Exact Sciences Corporation | 2 | $32 |
| Novo Nordisk Inc | 1 | $25 |
Products named: DEXCOM G7 GSS (161), PRECIVITYAD2, FANAPT, INFUSE, TRELEGY ELLIPTA, JARDIANCE, Kerendia, Heplisav-B.
Industry payments across TN — which companies pay providers there.
